← Back to headlines
Celularity Regains Nasdaq Compliance
Biotechnology company Celularity has announced it has regained compliance with Nasdaq listing requirements following a previously delayed financial filing.
1 May, 20:43 — 1 May, 20:43
Sources
Showing 1 of 1 sources
